UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 453

Sortiert nach

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension

Journal of human hypertension, 2011-10, Vol.25 (10), p.615-622

2011

Volltextzugriff (PDF)

Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study

International journal of clinical practice (Esher), 2010-09, Vol.64 (10), p.1367-1374

2010

Volltextzugriff (PDF)

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure trial (Val-HeFT)

Circulation (New York, N.Y.), 2003-03, Vol.107 (9), p.1278-1283

2003

Volltextzugriff (PDF)

Achieving blood pressure goal: initial therapy with valsartan hydrochlorothiazide combination compared with monotherapy

Journal of human hypertension, 2010-12, Vol.24 (12), p.823-830

2010

Volltextzugriff (PDF)

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy

Current medical research and opinion, 2009-11, Vol.25 (11), p.2655-2662

2009

Volltextzugriff (PDF)

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy

Current medical research and opinion, 2009-02, Vol.25 (2), p.315-324

2009

Volltextzugriff (PDF)

Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

Journal of cardiac failure, 1999-06, Vol.5 (2), p.155-160

1999

Volltextzugriff (PDF)

Site-differential gastrointestinal absorption in benazepril hydrochloride in healthy volunteers

Pharmaceutical research, 1994-03, Vol.11 (3), p.432-437

1994

Volltextzugriff (PDF)

Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure : Results from val-HeFT

Circulation (New York, N.Y.), 2005-08, Vol.112 (8), p.1121-1127

2005

Volltextzugriff (PDF)

Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study: Long-term administration of amlodipine/valsartan in hypertensive patients

International journal of clinical practice (Esher), 2010-09, Vol.64 (10), p.1367-1374

2010

Volltextzugriff (PDF)

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT

European journal of heart failure, 2004-12, Vol.6 (7), p.937-945

2004

Volltextzugriff (PDF)

ANTIHYPERTENSIVE EFFICACY OF AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE TRIPLE COMBINATION IN PATIENTS WITH OBESITY: A SUBGROUP ANALYSIS: PP.34.421

Journal of hypertension, 2010-06, Vol.28, p.e575

2010

Volltextzugriff (PDF)

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)

The American heart journal, 2004-12, Vol.148 (6), p.951-957

2004

Volltextzugriff (PDF)

A Convenient Method for the Synthesis of β-Lactams via 1-Methyl-2-halopyridinium Salts

Synthesis (Stuttgart), 1979, Vol.1979 (3), p.210-213

1979

Volltextzugriff (PDF)

A Convenient Method for the Synthesis of ß-Lactams via 1-Methyl-2-halopyridinium Salts

Synthesis (Stuttgart), 1979, Vol.1979 (3), p.210-213

1979

Volltextzugriff (PDF)

Heterocyclic. Compounds. X. Bis(2-chloroethyl)amino substituted β-lactams as potential antineoplastic agents

Journal of heterocyclic chemistry, 1979-03, Vol.16 (2), p.283-288

1979

Volltextzugriff (PDF)

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Science translational medicine, 2017-02, Vol.9 (375)

2017

Volltextzugriff (PDF)

Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension

Journal of the American College of Cardiology, 2016-12, Vol.68 (23), p.2525-2536

2016

Volltextzugriff (PDF)

Blood Pressure Control and Risk of Incident Atrial Fibrillation

American journal of hypertension, 2008-10, Vol.21 (10), p.1111-1116

2008

Volltextzugriff (PDF)

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation

The lancet respiratory medicine, 2014-07, Vol.2 (7), p.557-565

2014

Volltextzugriff (PDF)

Sea-Floor Spreading Event Captured by Seismometers

Science (American Association for the Advancement of Science), 2006-12, Vol.314 (5807), p.1920-1922

2006

Volltextzugriff (PDF)

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure

Nature genetics, 2011-10, Vol.43 (10), p.1005-1011

2011

Volltextzugriff (PDF)

Modular skeletal evolution in sticklebacks is controlled by additive and clustered quantitative trait Loci

Genetics (Austin), 2014-05, Vol.197 (1), p.405-420

2014

Volltextzugriff (PDF)

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials

Respiratory research, 2013-07, Vol.14 (1), p.73-73

2013

Volltextzugriff (PDF)

1 – 25 von 453

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(348)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(295)
Life Sciences & Biomedicine
(258)
Humans
(245)
Female
(149)
Biological And Medical Sciences
(148)
Male
(145)
Medical Sciences
(126)
Middle Aged
(116)
Adult
(97)
Aged
(87)
Animals
(47)
Radiology, Nuclear Medicine & Medical Imaging
(36)
Pharmacology. Drug Treatments
(34)
Tomography, X-Ray Computed
(34)
Adolescent
(30)
General & Internal Medicine
(30)
Genetics & Heredity
(29)
Pharmacology & Pharmacy
(29)
Aged, 80 And Over
(28)
Cardiovascular System & Cardiology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension

Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure trial (Val-HeFT)

Achieving blood pressure goal: initial therapy with valsartan hydrochlorothiazide combination compared with monotherapy

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy

Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

Site-differential gastrointestinal absorption in benazepril hydrochloride in healthy volunteers

Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure : Results from val-HeFT

Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study: Long-term administration of amlodipine/valsartan in hypertensive patients

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT

ANTIHYPERTENSIVE EFFICACY OF AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE TRIPLE COMBINATION IN PATIENTS WITH OBESITY: A SUBGROUP ANALYSIS: PP.34.421

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)

A Convenient Method for the Synthesis of β-Lactams via 1-Methyl-2-halopyridinium Salts

A Convenient Method for the Synthesis of ß-Lactams via 1-Methyl-2-halopyridinium Salts

Heterocyclic. Compounds. X. Bis(2-chloroethyl)amino substituted β-lactams as potential antineoplastic agents

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension

Blood Pressure Control and Risk of Incident Atrial Fibrillation

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation

Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization

Sea-Floor Spreading Event Captured by Seismometers

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure

Modular skeletal evolution in sticklebacks is controlled by additive and clustered quantitative trait Loci

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials

Suchergebnisse filtern